Logo image of GRDN

GUARDIAN PHRMCY SERVICES-A (GRDN) Stock Fundamental Analysis

NYSE:GRDN - US40145W1018 - Common Stock

26.42 USD
+0.27 (+1.03%)
Last: 8/29/2025, 8:27:28 PM
26.42 USD
0 (0%)
After Hours: 8/29/2025, 8:27:28 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to GRDN. GRDN was compared to 41 industry peers in the Consumer Staples Distribution & Retail industry. GRDN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, GRDN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year GRDN has reported negative net income.
In the past year GRDN had a positive cash flow from operations.
GRDN had positive earnings in 4 of the past 5 years.
In the past 5 years GRDN always reported a positive cash flow from operatings.
GRDN Yearly Net Income VS EBIT VS OCF VS FCFGRDN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

The Return On Assets of GRDN (-25.70%) is worse than 90.24% of its industry peers.
GRDN has a worse Return On Equity (-54.00%) than 80.49% of its industry peers.
Industry RankSector Rank
ROA -25.7%
ROE -54%
ROIC N/A
ROA(3y)-3.89%
ROA(5y)0.88%
ROE(3y)30.17%
ROE(5y)42.1%
ROIC(3y)N/A
ROIC(5y)N/A
GRDN Yearly ROA, ROE, ROICGRDN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

With a Gross Margin value of 19.63%, GRDN perfoms like the industry average, outperforming 41.46% of the companies in the same industry.
GRDN's Gross Margin has been stable in the last couple of years.
GRDN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5Y-0.64%
GRDN Yearly Profit, Operating, Gross MarginsGRDN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

More info and screens

6

2. Health

2.1 Basic Checks

GRDN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GRDN has been increased compared to 1 year ago.
Compared to 5 years ago, GRDN has more shares outstanding
GRDN has a better debt/assets ratio than last year.
GRDN Yearly Shares OutstandingGRDN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
GRDN Yearly Total Debt VS Total AssetsGRDN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 8.75 indicates that GRDN is not in any danger for bankruptcy at the moment.
The Altman-Z score of GRDN (8.75) is better than 95.12% of its industry peers.
GRDN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.75
ROIC/WACCN/A
WACC8.89%
GRDN Yearly LT Debt VS Equity VS FCFGRDN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 50M 100M

2.3 Liquidity

A Current Ratio of 1.18 indicates that GRDN should not have too much problems paying its short term obligations.
GRDN has a Current ratio of 1.18. This is comparable to the rest of the industry: GRDN outperforms 53.66% of its industry peers.
GRDN has a Quick Ratio of 1.18. This is a bad value and indicates that GRDN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.88, GRDN is in the better half of the industry, outperforming 70.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 0.88
GRDN Yearly Current Assets VS Current LiabilitesGRDN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for GRDN have decreased strongly by -567.05% in the last year.
Looking at the last year, GRDN shows a quite strong growth in Revenue. The Revenue has grown by 17.42% in the last year.
GRDN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.96% yearly.
EPS 1Y (TTM)-567.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%576.33%
Revenue 1Y (TTM)17.42%
Revenue growth 3Y15.75%
Revenue growth 5Y11.96%
Sales Q2Q%5.46%

3.2 Future

Based on estimates for the next years, GRDN will show a very strong growth in Earnings Per Share. The EPS will grow by 42.67% on average per year.
Based on estimates for the next years, GRDN will show a quite strong growth in Revenue. The Revenue will grow by 8.75% on average per year.
EPS Next Y159.58%
EPS Next 2Y67.33%
EPS Next 3Y42.67%
EPS Next 5YN/A
Revenue Next Year14.43%
Revenue Next 2Y8.2%
Revenue Next 3Y8.75%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GRDN Yearly Revenue VS EstimatesGRDN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
GRDN Yearly EPS VS EstimatesGRDN Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 0.5 -0.5 1 -1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

GRDN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 26.98, the valuation of GRDN can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GRDN is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.76, GRDN is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 26.98
GRDN Price Earnings VS Forward Price EarningsGRDN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

GRDN's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. GRDN is more expensive than 65.85% of the companies in the same industry.
Industry RankSector Rank
P/FCF 47.75
EV/EBITDA N/A
GRDN Per share dataGRDN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

GRDN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GRDN's earnings are expected to grow with 42.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y67.33%
EPS Next 3Y42.67%

More info and screens

0

5. Dividend

5.1 Amount

GRDN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GUARDIAN PHRMCY SERVICES-A

NYSE:GRDN (8/29/2025, 8:27:28 PM)

After market: 26.42 0 (0%)

26.42

+0.27 (+1.03%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-10 2025-11-10
Inst Owners48.29%
Inst Owner Change75.29%
Ins Owners3.92%
Ins Owner Change-117.1%
Market Cap1.67B
Analysts84.44
Price Target27.88 (5.53%)
Short Float %2.73%
Short Ratio2.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-14.87%
Min EPS beat(2)-18.3%
Max EPS beat(2)-11.45%
EPS beat(4)1
Avg EPS beat(4)-287.21%
Min EPS beat(4)-1131.99%
Max EPS beat(4)12.89%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.43%
Min Revenue beat(2)0.51%
Max Revenue beat(2)2.36%
Revenue beat(4)3
Avg Revenue beat(4)1.07%
Min Revenue beat(4)-0.25%
Max Revenue beat(4)2.36%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)9.33%
EPS NQ rev (1m)2.86%
EPS NQ rev (3m)-10%
EPS NY rev (1m)-0.69%
EPS NY rev (3m)-2.05%
Revenue NQ rev (1m)4.93%
Revenue NQ rev (3m)4.98%
Revenue NY rev (1m)3.78%
Revenue NY rev (3m)4.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 26.98
P/S 1.26
P/FCF 47.75
P/OCF 30.98
P/B 9.87
P/tB 22.07
EV/EBITDA N/A
EPS(TTM)-1.52
EYN/A
EPS(NY)0.98
Fwd EY3.71%
FCF(TTM)0.55
FCFY2.09%
OCF(TTM)0.85
OCFY3.23%
SpS20.95
BVpS2.68
TBVpS1.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.7%
ROE -54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.63%
FCFM 2.64%
ROA(3y)-3.89%
ROA(5y)0.88%
ROE(3y)30.17%
ROE(5y)42.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5Y-0.64%
F-Score5
Asset Turnover3.72
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 87.56%
Cap/Sales 1.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 0.88
Altman-Z 8.75
F-Score5
WACC8.89%
ROIC/WACCN/A
Cap/Depr(3y)87.95%
Cap/Depr(5y)73.67%
Cap/Sales(3y)1.52%
Cap/Sales(5y)1.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-567.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%576.33%
EPS Next Y159.58%
EPS Next 2Y67.33%
EPS Next 3Y42.67%
EPS Next 5YN/A
Revenue 1Y (TTM)17.42%
Revenue growth 3Y15.75%
Revenue growth 5Y11.96%
Sales Q2Q%5.46%
Revenue Next Year14.43%
Revenue Next 2Y8.2%
Revenue Next 3Y8.75%
Revenue Next 5YN/A
EBIT growth 1Y-253.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year256.29%
EBIT Next 3Y56.73%
EBIT Next 5YN/A
FCF growth 1Y-26.08%
FCF growth 3Y-5.46%
FCF growth 5Y-0.01%
OCF growth 1Y-18.16%
OCF growth 3Y-0.31%
OCF growth 5Y0.63%